Literature DB >> 31175858

Clinical-pathological correlations of BAV and the attendant thoracic aortopathies. Part 2: Pluridisciplinary perspective on their genetic and molecular origins.

Ares Pasipoularides1.   

Abstract

Bicuspid aortic valve (BAV) arises during valvulogenesis when 2 leaflets/cusps of the aortic valve (AOV) are fused together. Its clinical manifestations pertain to faulty AOV function, the associated aortopathy, and other complications surveyed in Part 1 of the present bipartite-series. Part 2 examines mainly genetic and epigenetic causes of BAV and BAV-associated aortopathies (BAVAs) and disease syndromes (BAVD). Part 1 explored the heterogeneity among subsets of patients with BAV and BAVA/BAVD, and investigated abnormal fluid dynamic stress and strain patterns sustained by the cusps. Specific BAV morphologies engender systolic outflow asymmetries, associated with abnormal aortic regional wall-shear-stress distributions and the expression/localization of BAVAs. Understanding fluid dynamic factors besides the developmental mechanisms and underlying genetics governing these congenital anomalies is necessary to explain patient predisposition to aortopathy and phenotypic heterogeneity. BAV aortopathy entails complex/multifactorial pathophysiology, involving alterations in genetics, epigenetics, hemodynamics, and in cellular and molecular pathways. There is always an interdependence between organismic developmental signals and genes-no systemic signals, no gene-expression; no active gene, no next step. An apposite signal induces the expression of the next developmental gene, which needs be expressed to trigger the next signal, and so on. Hence, embryonic, then post-partum, AOV and thoracic aortic development comprise cascades of developmental genes and their regulation. Interdependencies between them arise, entailing reciprocal/cyclical mutual interactions and adaptive feedback loops, by which developmental morphogenetic processes self-correct responding to environmental inputs/reactions. This Survey can serve as a reference point and driver for further pluridisciplinary BAV/BAVD studies and their clinical translation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BAV-aortopathy; BAV-associated syndromes or disease; Bicuspid aortic valve (BAV); Congenital cardiovascular disease; Extracellular matrix; Genetic screening; NGS; Polygenic/multifactorial complex-disease traits; Thoracic aortic dilatations; Valvulogenesis; Vascular smooth muscle cell

Mesh:

Year:  2019        PMID: 31175858      PMCID: PMC6688480          DOI: 10.1016/j.yjmcc.2019.05.022

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  149 in total

Review 1.  The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression.

Authors:  J D Molkentin
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

2.  Diastolic right ventricular filling vortex in normal and volume overload states.

Authors:  Ares Pasipoularides; Ming Shu; Ashish Shah; Michael S Womack; Donald D Glower
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04       Impact factor: 4.733

3.  RV functional imaging: 3-D echo-derived dynamic geometry and flow field simulations.

Authors:  Ares D Pasipoularides; Ming Shu; Michael S Womack; Ashish Shah; Olaf Von Ramm; Donald D Glower
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09-12       Impact factor: 4.733

4.  Right ventricular diastolic relaxation in conscious dog models of pressure overload, volume overload, and ischemia.

Authors:  Ares D Pasipoularides; Ming Shu; Ashish Shah; Donald D Glower
Journal:  J Thorac Cardiovasc Surg       Date:  2002-11       Impact factor: 5.209

5.  Gata5 is required for the development of the heart and endoderm in zebrafish.

Authors:  J F Reiter; J Alexander; A Rodaway; D Yelon; R Patient; N Holder; D Y Stainier
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

6.  Right ventricular diastolic function in canine models of pressure overload, volume overload, and ischemia.

Authors:  Ares Pasipoularides; Ming Shu; Ashish Shah; Scott Silvestry; Donald D Glower
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

7.  Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve.

Authors:  Hisayo Yasuda; Satoshi Nakatani; Marie Stugaard; Yuko Tsujita-Kuroda; Ko Bando; Junjiro Kobayashi; Masakazu Yamagishi; Masafumi Kitakaze; Soichiro Kitamura; Kunio Miyatake
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

8.  Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm.

Authors:  Maria Nataatmadja; Malcolm West; Jenny West; Kim Summers; Philip Walker; Michio Nagata; Teruo Watanabe
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

9.  p300 acts as a transcriptional coactivator for mammalian Notch-1.

Authors:  F Oswald; B Täuber; T Dobner; S Bourteele; U Kostezka; G Adler; S Liptay; R M Schmid
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  RV instantaneous intraventricular diastolic pressure and velocity distributions in normal and volume overload awake dog disease models.

Authors:  Ares Pasipoularides; Ming Shu; Ashish Shah; Alessandro Tucconi; Donald D Glower
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-11-06       Impact factor: 4.733

View more
  1 in total

Review 1.  Genetics in bicuspid aortic valve disease: Where are we?

Authors:  Katia Bravo-Jaimes; Siddharth K Prakash
Journal:  Prog Cardiovasc Dis       Date:  2020-06-27       Impact factor: 8.194

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.